Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
END Clinic Smoking Cessation Program
NCT03290430Phase 1Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 1, open-label trial in nicotine dependence, sponsored by Case Comprehensive Cancer Center. Primary endpoint: Rate of 24 hour smoking abstinence across intervention. Started Jan 2018; status: completed.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03290430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290430.